Skip to main content
. Author manuscript; available in PMC: 2014 Dec 22.
Published in final edited form as: Pediatr Blood Cancer. 2008 Apr;50(4):779–783. doi: 10.1002/pbc.21287

TABLE II.

Reasons for Discontinuation of TMP-SMZ

92 Patients from January 1, 2005 to November 30, 2005
Myelosuppression 53%
Drug allergy 13%
Inability to take oral medications 7%
Noncompliance 7%
Mucositis 4%
Transferred from another institution 2%
Elevated liver function tests 1%
Liver fibrosis 1%
Liver failure 1%
Congenital neutropenia 1%
G6PD deficiency 1%
Autoimmune enteropathy 1%
Insurance 1%
Unknown 7%